This report describes and explains the life sciences IT market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global life sciences IT market reached a value of nearly $29.14 billion in 2025, having grown at a compound annual growth rate (CAGR) of 12.1% since 2020. The market is expected to grow from $29.14 billion in 2025 to $49.79 billion in 2030 at a rate of 11.3%. The market is then expected to grow at a CAGR of 10.6% from 2030 and reach $82.24 billion in 2035.
Growth in the historic period resulted from increasing pharmaceutical research and development (R&D) spending, expansion of precision medicine and genomics research, growing number of clinical trials and growing focus on drug safety monitoring. Factors that negatively affected growth in the historic period were data privacy concern and high implementation costs.
Going forward, rising healthcare spending, growing demand for real-world evidence (RWE) and advanced data analytics, increasing government support for medical research and growing volume of biomedical data will drive the growth. Factors that could hinder the growth of the life sciences IT market in the future include integration challenges with legacy IT infrastructure, strict regulatory compliance requirements and impact of trade wars and tariffs.
Market trends for the life sciences IT market include integration of quantum computing and advanced computational platforms in life sciences, adoption of AI-driven commercialization and marketing automation platforms, development of cloud-based inspection and AI-driven manufacturing analytics platforms, and expansion of cloud-based engagement and data integration platforms.
The life sciences IT market is segmented by type into software and service. The service market was the largest segment of the life sciences IT market segmented by type, accounting for 60.9% or $17.74 billion of the total in 2025. Going forward, the software segment is expected to be the fastest-growing segment in the life sciences IT market segmented by type, at a CAGR of 12.7% during 2025-2030.
The life sciences IT market is segmented by solution into drug discovery informatics, clinical trial management, bioinformatics, laboratory information management and other solutions. The drug discovery informatics was the largest segment of the life sciences IT market segmented by solution, accounting for 29.8% or $8.67 billion of the total in 2025. Going forward, the bioinformatics segment is expected to be the fastest-growing segment in the life sciences IT market segmented by solution, at a CAGR of 12.7% during 2025-2030.
The life sciences IT market is segmented by end user into pharmaceutical and biotechnology companies, contract research and development organizations and other end users. The pharmaceutical and biotechnology companies market was the largest segment of the life sciences IT market segmented by end user, accounting for 63.1% or $18.39 billion of the total in 2025. Going forward, the contract research and development organizations segment is expected to be the fastest-growing segment in the life sciences IT market segmented by end user, at a CAGR of 13% during 2025-2030.
North America was the largest region in the life sciences IT market, accounting for 36.4% or $10.61 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the life sciences IT market will be Asia Pacific and Eastern Europe where growth will be at CAGRs of 13.2% and 11.4% respectively. These will be followed by Western Europe and North America where the markets are expected to grow at CAGRs of 11.2% and 10.3% respectively.
The global life sciences IT market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 18.51% of the total market in 2024. IQVIA Holdings Inc. was the largest competitor with a 2.35% share of the market, followed by Oracle Corp. with 2.25%, Accenture plc with 2.11%, Veeva Systems, with 2.10%, SAP SE, with 2.05%, International Business Machines Corp. with 1.98%, Cognizant Technology Solutions Corporation with 1.81%, SAS Institute Inc. (Statistical Analysis System) with 1.66%, Dassault Systems SE (Medidata Solution Inc.) with 1.65% and Persistent Systems with 0.55%.
The top opportunities in the life sciences IT market segmented by type will arise in the service segment, which will gain $11.31 billion of global annual sales by 2030. The top opportunities in the life sciences IT market segmented by solution will arise in the drug discovery informatics segment, which will gain $6.05 billion of global annual sales by 2030. The top opportunities in the life sciences IT market segmented by end user will arise in the pharmaceutical and biotechnology companies segment, which will gain $12.52 billion of global annual sales by 2030. The life sciences IT market size will gain the most in the USA at $6.1 billion.
Player-adopted strategies in the life sciences IT market include focus on enhancing its business operations through new launches and strategic partnerships.
Market-trend-based strategies for the life sciences IT market include focus on the development of quantum computing, enabled research platforms, advanced computational chemistry tools and integrated digital discovery environments, development of artificial intelligence-driven commercialization platforms, cloud-based marketing ecosystems and advanced data analytics tools, cloud-based inspection platforms, artificial intelligence-driven analytics and integrated manufacturing data systems to improve operational visibility and quality control across pharmaceutical production environments and advanced analytics systems and integrated digital ecosystems to improve collaboration and data-driven decision-making across pharmaceutical and biotechnology organizations.
To take advantage of the opportunities, the analyst recommends the life sciences IT companies to focus on quantum-enabled integrated discovery ecosystems, focus on AI driven commercialization platforms in life sciences IT, focus on integrated ai driven cloud inspection platforms for manufacturing visibility, focus on integrated cloud ecosystems and data-driven collaboration in life sciences IT, focus on expanding software driven life sciences IT solutions for high growth analytics and saas adoption, focus on strengthening geographic and digital distribution channels for life sciences IT expansion, focus on value linked pricing and contract structuring in life sciences IT, focus on digital-first targeted promotion for life sciences IT buyers, focus on multi-channel scientific credibility promotion, focus on domain skilled talent and user enablement across life sciences IT adoption.
This product will be delivered within 3-5 business days.
The global life sciences IT market reached a value of nearly $29.14 billion in 2025, having grown at a compound annual growth rate (CAGR) of 12.1% since 2020. The market is expected to grow from $29.14 billion in 2025 to $49.79 billion in 2030 at a rate of 11.3%. The market is then expected to grow at a CAGR of 10.6% from 2030 and reach $82.24 billion in 2035.
Growth in the historic period resulted from increasing pharmaceutical research and development (R&D) spending, expansion of precision medicine and genomics research, growing number of clinical trials and growing focus on drug safety monitoring. Factors that negatively affected growth in the historic period were data privacy concern and high implementation costs.
Going forward, rising healthcare spending, growing demand for real-world evidence (RWE) and advanced data analytics, increasing government support for medical research and growing volume of biomedical data will drive the growth. Factors that could hinder the growth of the life sciences IT market in the future include integration challenges with legacy IT infrastructure, strict regulatory compliance requirements and impact of trade wars and tariffs.
Market trends for the life sciences IT market include integration of quantum computing and advanced computational platforms in life sciences, adoption of AI-driven commercialization and marketing automation platforms, development of cloud-based inspection and AI-driven manufacturing analytics platforms, and expansion of cloud-based engagement and data integration platforms.
The life sciences IT market is segmented by type into software and service. The service market was the largest segment of the life sciences IT market segmented by type, accounting for 60.9% or $17.74 billion of the total in 2025. Going forward, the software segment is expected to be the fastest-growing segment in the life sciences IT market segmented by type, at a CAGR of 12.7% during 2025-2030.
The life sciences IT market is segmented by solution into drug discovery informatics, clinical trial management, bioinformatics, laboratory information management and other solutions. The drug discovery informatics was the largest segment of the life sciences IT market segmented by solution, accounting for 29.8% or $8.67 billion of the total in 2025. Going forward, the bioinformatics segment is expected to be the fastest-growing segment in the life sciences IT market segmented by solution, at a CAGR of 12.7% during 2025-2030.
The life sciences IT market is segmented by end user into pharmaceutical and biotechnology companies, contract research and development organizations and other end users. The pharmaceutical and biotechnology companies market was the largest segment of the life sciences IT market segmented by end user, accounting for 63.1% or $18.39 billion of the total in 2025. Going forward, the contract research and development organizations segment is expected to be the fastest-growing segment in the life sciences IT market segmented by end user, at a CAGR of 13% during 2025-2030.
North America was the largest region in the life sciences IT market, accounting for 36.4% or $10.61 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the life sciences IT market will be Asia Pacific and Eastern Europe where growth will be at CAGRs of 13.2% and 11.4% respectively. These will be followed by Western Europe and North America where the markets are expected to grow at CAGRs of 11.2% and 10.3% respectively.
The global life sciences IT market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 18.51% of the total market in 2024. IQVIA Holdings Inc. was the largest competitor with a 2.35% share of the market, followed by Oracle Corp. with 2.25%, Accenture plc with 2.11%, Veeva Systems, with 2.10%, SAP SE, with 2.05%, International Business Machines Corp. with 1.98%, Cognizant Technology Solutions Corporation with 1.81%, SAS Institute Inc. (Statistical Analysis System) with 1.66%, Dassault Systems SE (Medidata Solution Inc.) with 1.65% and Persistent Systems with 0.55%.
The top opportunities in the life sciences IT market segmented by type will arise in the service segment, which will gain $11.31 billion of global annual sales by 2030. The top opportunities in the life sciences IT market segmented by solution will arise in the drug discovery informatics segment, which will gain $6.05 billion of global annual sales by 2030. The top opportunities in the life sciences IT market segmented by end user will arise in the pharmaceutical and biotechnology companies segment, which will gain $12.52 billion of global annual sales by 2030. The life sciences IT market size will gain the most in the USA at $6.1 billion.
Player-adopted strategies in the life sciences IT market include focus on enhancing its business operations through new launches and strategic partnerships.
Market-trend-based strategies for the life sciences IT market include focus on the development of quantum computing, enabled research platforms, advanced computational chemistry tools and integrated digital discovery environments, development of artificial intelligence-driven commercialization platforms, cloud-based marketing ecosystems and advanced data analytics tools, cloud-based inspection platforms, artificial intelligence-driven analytics and integrated manufacturing data systems to improve operational visibility and quality control across pharmaceutical production environments and advanced analytics systems and integrated digital ecosystems to improve collaboration and data-driven decision-making across pharmaceutical and biotechnology organizations.
To take advantage of the opportunities, the analyst recommends the life sciences IT companies to focus on quantum-enabled integrated discovery ecosystems, focus on AI driven commercialization platforms in life sciences IT, focus on integrated ai driven cloud inspection platforms for manufacturing visibility, focus on integrated cloud ecosystems and data-driven collaboration in life sciences IT, focus on expanding software driven life sciences IT solutions for high growth analytics and saas adoption, focus on strengthening geographic and digital distribution channels for life sciences IT expansion, focus on value linked pricing and contract structuring in life sciences IT, focus on digital-first targeted promotion for life sciences IT buyers, focus on multi-channel scientific credibility promotion, focus on domain skilled talent and user enablement across life sciences IT adoption.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Life Sciences IT Market, Overview of Key Products/Services
8 Major Market Trends
9 Life Sciences IT Growth Analysis and Strategic Analysis Framework
10 Global Life Sciences IT Market Size and Growth Analysis
11 Global Life Sciences IT Total Addressable Market (TAM) Analysis
12 Global Life Sciences IT Market Segmentation
13 Life Sciences IT Market, Regional and Country Analysis
14 Asia-Pacific Market
15 South East Asia Market
16 Western Europe Market
17 Eastern Europe Market
18 North America Market
19 South America Market
20 Middle East Market
21 Africa Market
22 Competitive Landscape and Company Profiles
23 Other Major and Innovative Companies
26 Life Sciences IT Market - Company Scoring Matrix
28 Key Mergers and Acquisitions
29 Recent Developments in the Life Sciences IT Market
30 Opportunities and Strategies
31 Life Sciences IT Market, Conclusions and Recommendations
32 Appendix
Executive Summary
Life Sciences IT Global Market Opportunities and Strategies to 2035 provides the strategists; marketers and senior management with the critical information they need to assess the global life sciences IT market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for life sciences IT? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The life sciences IT market global report answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider life sciences IT market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market
- Growth Analysis and Strategic Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Regional and Country Analysis - Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type, by solution and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size and Growth - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard - Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Recent Developments Information on recent developments in the market covered in the report.
- Market Opportunities and Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations - This section includes recommendations for life sciences IT providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type: Software; Service
2) By Solution: Drug Discovery Informatics; Clinical Trial Management; Bioinformatics; Laboratory Information Management; Other Solutions
3) By End User: Pharmaceutical and Biotechnology Companies; Contract Research and Development Organizations; Other End Users
Companies Mentioned: IQVIA Holdings Inc; Oracle Corp; Accenture plc; Veeva Systems; SAP SE.
Countries: China; Germany; Japan; UK; France; India; USA; Canada; South Korea; Brazil; Australia; Russia; Spain; Italy; Indonesia; Taiwan
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; life sciences IT indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""
Companies Mentioned
- IQVIA Holdings Inc
- Oracle Corp
- Accenture plc
- Veeva Systems
- SAP SE.
- International Business Machines Corp.
- Cognizant Technology Solutions Corporation
- SAS Institute Inc. (Statistical Analysis System)
- Dassault Systems SE (Medidata Solution Inc.)
- Persistent Systems
- Great Robotics Corporation
- Beijing Tuodao Medical Technology Co., Ltd.
- Curexo, Inc.
- Koh Young Technology Inc.
- CMR Surgical Ltd.
- Moon Surgical SAS
- Quantum Surgical SAS
- Smith & Nephew plc
- Siemens Healthineers AG
- Intuitive Surgical, Inc.
- Stryker Corporation
- Johnson & Johnson
- Zimmer Biomet Holdings, Inc.
- THINK Surgical, Inc.
- Activ Surgical, Inc.
- Stereotaxis, Inc.
- Globus Medical, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 353 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 29.14 Billion |
| Forecasted Market Value ( USD | $ 82.24 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
